Medical News

RSS

WHO names Johns Hopkins International Injury Research Unit as 'collaborating center'

The Johns Hopkins Bloomberg School of Public Health today announced that its Department of International Health and International Injury Research Unit have been designated a "collaborating center" by the World Health Organization. The new WHO Collaborating Center for Injuries, Violence and Accident Prevention is only the third collaborating center in the United States to focus on injury prevention and joins a network of more than 800 WHO Collaborating Centers in more than 80 countries.

2 Nov 2010

New wiring diagram shows how brain organizes information

University of Utah (U of U) medical researchers have uncovered a wiring diagram that shows how the brain pays attention to visual, cognitive, sensory, and motor cues. The research provides a critical foundation for the study of abnormalities in attention that can be seen in many brain disorders such as autism, schizophrenia, and attention deficit disorder.

2 Nov 2010

Researchers explain how adiponectin prevents stress-induced damage in heart

One of the many advantages of maintaining a normal body weight is having healthy fat, which in turn supports a healthy heart. Fat tissue is increasingly seen as more than just a storage depot - it's also an active secretory organ that normally produces high levels of a cardioprotective hormone called adiponectin. How adiponectin protects the hearts of healthy people has long been a mystery, and now a team led by Barbara Ranscht, Ph.D. and Pilar Ruiz-Lozano, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveals that the protein T-cadherin is the receptor that anchors adiponectin to heart cells.

2 Nov 2010

LSU Health Sciences Center New Orleans awarded top Psychiatric Services honor

The Department of Psychiatry at LSU Health Sciences Center New Orleans has been given the 2010 Gold Achievement Award by the American Psychiatric Association for a program credited by the St. Bernard Parish Public School System as key to reopening schools and recovery of the community after Hurricane Katrina. This is the top Psychiatric Services honor bestowed by the world's largest psychiatric organization.

2 Nov 2010

New targeted therapy shows positive results in patients with lung cancer

A UC Irvine oncologist's work with a targeted therapy is showing great promise in patients with a deadly form of lung cancer. The results were published Thursday in the New England Journal of Medicine.

2 Nov 2010

AEHN awards document management services contract to WorkflowOne

WorkflowOne, a leading provider of print management, marketing and distribution services today announced today that the Albert Einstein Healthcare Network (AEHN), a private, not-for-profit organization, has awarded WorkflowOne with a contract for document management services for the healthcare organization's nine major facilities and numerous outpatient centers.

2 Nov 2010

Micronutrient Initiative receives $75 million to expand innovative nutrition programming

Minister of International Cooperation, Beverley Oda, has announced $75 million in new funding for the work of the Micronutrient Initiative to expand innovative nutrition programming and strengthen African health systems. The investment will be spread over five years and is expected to benefit 4 million pregnant women and 14 million children under the age of five - particularly in sub-Saharan Africa.

2 Nov 2010

Eye transformer impacts JAK/STAT-signaling pathway response with microbial challenge

Scientists are keeping their eye on a new discovery published in the November 2011 print issue of the FASEB Journal (http://www.fasebj.org) that explains what causes some genes to go out of control. Scientists have identified a "cellular switch," called eye transformer, that controls the flow of information from chemical signals outside of the cell to genes in the cell nucleus.

2 Nov 2010

Brain MRI could predict duration of stroke onset

Magnetic resonance imaging (MRI) of the brain could expand the number of stroke patients eligible for a potentially life-saving treatment, according to a new study, published online and in the December issue of the journal Radiology.

2 Nov 2010

Effective treatment for brain cancer in daffodils

When looking for new ways to treat aggressive brain cancers, an international team of scientists turned a new leaf and "discovered" the lowly daffodil. A new research study published in the November 2010 print issue of The FASEB Journal (http://www.fasebj.org) offers hope that a natural compound found in daffodil bulbs, called narciclasine, may be a powerful therapeutic against biologically aggressive forms of human brain cancers.

2 Nov 2010

Vacuum cleaner with UV technology effective at reducing carpet's surface microbes

New research suggests that the addition of ultraviolet light to the brushing and suction of a vacuum cleaner can almost double the removal of potentially infectious microorganisms from a carpet's surface when compared to vacuuming alone.

2 Nov 2010

SRA receives five-year contract to support NTP, NIEHS programmatic initiatives

SRA International, Inc., a leading provider of technology, research, and strategic consulting services and solutions to government organizations and commercial clients, today announced that the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) awarded the company a contract for up to five years to provide statistical, mathematical, bioinformatic, and computational expertise and support for the National Toxicology Program (NTP) and other NIEHS programmatic initiatives. The contract has a potential total dollar value of $15.5 million.

2 Nov 2010

Elekta awarded delivery of three Leksell Gamma Knife systems to Chinese hospitals

In winning a tender to deliver three Leksell Gamma Knifeâ models to hospitals in China, Elekta will help more cancer patients receive the therapy they need. The agreement also helps Elekta increase its leading market position in China.

From Elekta 2 Nov 2010

Provident launches Principals Fund I with $25 million of committed capital

Provident Healthcare Ventures, LLC is pleased to announce the launch of its inaugural Principals Fund I with $25 million of committed capital. All capital invested in the Fund will be provided by the principals of Provident, affirming their belief that providing early-stage healthcare services companies with crucial resources, such as capital and operating expertise, will significantly increase enterprise value over the life of the investment.

2 Nov 2010

NSAIDs drugs prevent colon cancer: Research

Nonsteroidal anti-inflammatory drugs (NSAIDs) prevent colon cancer by triggering diseased stem cells to self-destruct, according to researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine.

2 Nov 2010

$Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients$

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life. So when new, more efficient treatment methods are developed, one important question is whether better treatment comes at the cost of increased side effects and decreased quality of life.

2 Nov 2010

Defibtech named one of Connecticut’s 40 fastest growing technology companies

Defibtech, LLC, a leading innovator in the Automated External Defibrillator (AED) market, has been named as a 2010 Marcum Tech Top 40 winner, a celebration of the 40 fastest growing companies in Connecticut, and was honored on October 28, 2010 at the Tech Top 40 awards program at the Oakdale Theater in Wallingford, Conn. This is the fourth year that Defibtech has been named as one of the fastest growing technology companies in Connecticut. Selection was based on the percentage revenue growth during the four year period from 2006-2009.

2 Nov 2010

Vitrolife operating income increases 3% to SEK 25 million for January to September 2010

Vitrolife: Growth in local currency was 13 percent. Sales amounted to SEK 217 (207) million, corresponding to an increase of 4 percent in SEK. Operating income before research and development costs increased by 11 percent and amounted to SEK 58 (53) million.

2 Nov 2010

Positive preliminary data from Protalix's taliglucerase alfa switchover trial for Gaucher disease

Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).

2 Nov 2010

Innovative lifesaving device for patients with advanced heart failure

Bradley Cantley, 41, headed home from UC San Diego Medical Center connected to a lifesaving heart machine called a left ventricular assisted device (LVAD). For patients with advanced heart failure, the mechanical pump rapidly improves circulation throughout the body and serves as a bridge to transplant. Cantley is the first of many patients, locally and globally, who will benefit from the expanded heart surgery program at UC San Diego Health System.

2 Nov 2010

Medical News

WHO names Johns Hopkins International Injury Research Unit as 'collaborating center'

New wiring diagram shows how brain organizes information

Researchers explain how adiponectin prevents stress-induced damage in heart

LSU Health Sciences Center New Orleans awarded top Psychiatric Services honor

New targeted therapy shows positive results in patients with lung cancer

AEHN awards document management services contract to WorkflowOne

Micronutrient Initiative receives $75 million to expand innovative nutrition programming

Eye transformer impacts JAK/STAT-signaling pathway response with microbial challenge

Brain MRI could predict duration of stroke onset

Effective treatment for brain cancer in daffodils

Vacuum cleaner with UV technology effective at reducing carpet's surface microbes

SRA receives five-year contract to support NTP, NIEHS programmatic initiatives

Elekta awarded delivery of three Leksell Gamma Knife systems to Chinese hospitals

Provident launches Principals Fund I with $25 million of committed capital

NSAIDs drugs prevent colon cancer: Research

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

Defibtech named one of Connecticut’s 40 fastest growing technology companies

Vitrolife operating income increases 3% to SEK 25 million for January to September 2010

Positive preliminary data from Protalix's taliglucerase alfa switchover trial for Gaucher disease

Innovative lifesaving device for patients with advanced heart failure

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News